Jaime King
Senior Affiliated Scholar at the UCSF/UC Law SF Consortium on Law, Science, and Health Policy
Bio
Professor Jaime S. King is the John and Marylyn Mayo Chair in Health Law and Professor of Law at the University of Auckland, a Senior Affiliate Scholar to the UCSF/UC Law SF Consortium on Science, Law and Health Policy, and the Executive Editor of The Source for Healthcare Price and Competition. She is also a co-author of Health Law: Cases, Materials, and Problems, 8th ed. (2018).
Professor King’s research examines some of the most complex challenges facing healthcare systems. An advocate for health reform, Professor King focuses on the drivers of healthcare costs, with a special interest in market consolidation and efforts to improve transparency in healthcare pricing. These interests led her to found the Source on Healthcare Price and Competition, a multi-disciplinary web-based resource for information and analysis about healthcare price and competition. She has testified before Congress and state legislative hearings on issues related to healthcare consolidation, price transparency, and medical decision-making.
Professor King also presented her work at the National Academy of Medicine’s Leadership Consortium in 2020 on issues related to consolidation and pricing in health care. Professor King and her co-author, Erin Fuse Brown, won the Best Mergers and Antitrust Paper of 2017 presented at the American Antitrust Institute Annual Meeting for their article – The Anticompetitive Potential of Cross-Market Mergers, and she was the 2015 recipient of the Hastings Foundation Faculty Award for Outstanding Scholarship. She is also the 2020-2022 President of the Board of Directors for the American Society of Law, Medicine, and Ethics.
Professor King’s work has been published in Nature, Health Affairs, the New England Journal of Medicine, the UCLA Law Review, the Indiana Law Journal, the Journal of Law, Medicine and Ethics, the Yale Journal of Health Policy, Law and Ethics, the American Journal of Law and Medicine, Prenatal Diagnosis, Human Reproduction, the William and Mary Policy Review, the UC Law SF Journal, and the Hastings Womens’ Law Journal. Her work has also been referenced in the New York Times, the L.A. Times, the San Francisco Chronicle, the Atlantic Monthly, and Slate Magazine.
Education
-
Harvard University
Ph.D., Health Policy, Concentration in Ethics 2008 -
Emory University School of Law
J.D., Law 2001 -
Dartmouth College
BA, Psychology 1998
Selected Scholarship
-
Preventing Anticompetitive Healthcare Consolidation: Lessons from Five States
The Source on Healthcare Price Competition 2020 -
The Need for Health Reform
The New England Journal of Medicine 2020 -
The Secret of Health Care Prices: Why Transparency is in the Public Interest
California Health Care Foundation Report 2019 -
Addressing Health Care Market Consolidation and High Prices
Urban Institute Research Report 2019 -
California's Drug Transparency Law: Navigating the Boundaries of State Authority on Drug Pricing
Health Affairs 2018 -
The Legal Dimensions of Genomic Sequencing in Newborn Screening,
The Ethics of Sequencing Newborns: Recommendations and Reflections,(Hastings Center Special Report) 2018 -
Whole-Genome Screening of Newborns? The Constitutional Boundaries of Newborn Screening Programs
Pediatrics 2016 -
State Actions to Promote and Restrain Commercial Accountable Care Organizations
Milbank Memorial Fund Report 2015 -
Clarifying Costs: Can Increased Price Transparency Reduce Healthcare Spending?
William and Mary Policy Review 2013 -
Best Ethical Practices for Clinicians and Laboratories in the Provision of Non-Invasive Prenatal Testing
Prenatal Diagnosis 2013 -
Group Health's participation in a shared decision-making demonstration yielded lessons, such as role of culture change.
Health Affairs 2013